Fungal pathogen changes shape when bacteria are nearby

Cryptococcus neoformans and Mycobacterium tuberculosis are two opportunistic microbes that share the same parts of the world and can inhabit similar spaces in the human body. Both are recognised by the World Health Organization as high-priority pathogens, and clinicians are increasingly reporting cases where people carry both cryptococcosis and tuberculosis at the same time. Despite those clinical reports, experimental studies that look directly at how these pathogens interact are rare. In work led by Ivy M. Dambuza, researchers set out to test whether the fungus C. neoformans changes its behaviour when a mycobacterium is present. They used a physiologically relevant human plasma-like medium as the growth environment and introduced either heat-killed M. tuberculosis antigen or the live vaccine strain, M. bovis BCG. The team asked a straightforward question: does the presence of mycobacterial material influence fungal growth and traits linked to disease? Their experiments show that the fungus not only survives but responds actively to the bacterial signals, offering laboratory evidence that co-presence can change fungal biology in ways that are relevant to human infection.

To probe this inter-pathogen interaction, the researchers grew Cryptococcus neoformans in a human plasma-like medium and exposed it to two different mycobacterial conditions: heat-killed M. tuberculosis antigen and the live vaccine strain M. bovis BCG. Under both conditions the fungus increased in number compared with controls in the same medium. Beyond simple growth, the fungus showed changes in traits that are associated with its ability to cause disease: titan cell formation, capsule enlargement and increased survival from phagocytosis. Titan cells are enlarged fungal cells, capsule enlargement refers to remodelling of the capsular material that surrounds the yeast, and increased survival from phagocytosis means the fungus was harder for immune cells to eat and destroy. These results are reported directly from the controlled exposures described above and show that contact with mycobacterial components can drive measurable and specific changes in C. neoformans morphology and behavior.

The findings reported by Ivy M. Dambuza and colleagues provide a proof-of-principle that a dynamic, inter-pathogen interaction is possible between a fungus and a mycobacterium under conditions meant to mimic human plasma. That interaction led the fungus to diversify its morphologies and remodel its capsular material, traits that are tied to virulence. Because clinical co-infections of cryptococcosis and tuberculosis are on the rise, the laboratory observation that mycobacteria can push C. neoformans toward more virulent states suggests a biological mechanism that could worsen outcomes when both pathogens are present. The study does not claim to have mapped the full clinical picture, but it does highlight the need for more experimental and clinical work to understand how these microbes influence one another and what that means for patients living in regions where both pathogens circulate.